Bacterial Infections, Cirrhosis, Morality, Resistant Infection
Conditions
Brief summary
In recent years, there has been an increasing prevalence of bacterial infections caused by multiresistant and extremely resistant organisms in patients with cirrhosis. These infections are associated with a worse prognosis, generate difficulties in the management of the patient during hospitalization and increase health costs. The main objective of this project is to estimate the prevalence of infections by multiresistant bacteria in patients with cirrhosis. Additionally, the prevalence of other antibiotic resistance patterns and morbi-mortality in the study population will be evaluated. For these purposes, a multicenter prospective cohort study will be carried out, including patients with cirrhosis who present bacterial infections at the time of admission, or during hospitalization. Performing a study in Argentina on the clinical and microbiological characteristics of bacterial infections in patients with cirrhosis could be very useful to develop new strategies for prevention and treatment of this severe complication.
Interventions
This is an observational study without intervention
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with cirrhosis * Patients older than 17 years. * Patients who are hospitalized for bacterial infections, or who develop bacterial infections while hospitalized
Exclusion criteria
• Refusal to participate in the informed consent process
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To estimate the prevalence of infections caused by multi-resistant microorganisms in patients with cirrhosis | at the moment of the diagnosis of the bacerial infection |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate variables associated with infections caused by multi-resistant microorganisms in patients with cirrhosis | at the moment of the diagnosis of the bacerial infection |
| To evaluate the effect of infections caused by multi-resistant microorganisms on the in-hospital survival of patients with cirrhosis | 30 days |
Countries
Argentina